Altered Sphingolipids, Glycerophospholipids, and Lysophospholipids Reflect Disease Status in Idiopathic Steroid-Sensitive Nephrotic Syndrome in Children: A Non-Targeted Metabolomic Study
Cells · 2025
DOI: 10.3390/cells14241950 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Takahiro Kanai und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Jichi Medical University, 3311-1, Yakushiji, Shimotsuke 329-0498, Tochigi, Japan. Hauptthemen laut MEDLINE: Nephrotic Syndrome, Glycerophospholipids, Sphingolipids, Metabolomics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI, Kawano Masanori Memorial Foundation for the Promotion of Pediatrics.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Idiopathic steroid-sensitive nephrotic syndrome (ISSNS) is the most common glomerular disease in children, yet its molecular mechanisms and lipid-mediated pathophysiology remain poorly understood. In this study, we performed comprehensive non-targeted metabolomic analysis of serum samples obtained from children with ISSNS during both the nephrotic and remission phases to identify metabolic alterations associated with disease status. Using liquid chromatography–quadrupole time-of-flight mass spectrometry (LC-QTOF-MS), we profiled low-molecular-weight metabolites and identified significant alterations in several lipid classes, including sphingolipids, glycerophospholipids, and lysophospholipids. Several sphingomyelin and phosphatidylcholine species showed strong correlations with total cholesterol levels, reflecting lipid alterations consistent with the hyperlipidemic state that characterizes ISSNS. In contrast, oxidized phosphatidylcholines may more specifically reflect oxidative membrane injury and glomerular permeability changes associated with disease status. These findings highlight membrane lipid remodeling as a key feature of active disease and suggest potential lipid-based biomarkers for disease monitoring and therapeutic evaluation in pediatric ISSNS. This study provides a metabolomic framework for understanding lipid-driven mechanisms of ISSNS pathophysiology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Jichi Medical University, 3311-1, Yakushiji, Shimotsuke 329-0498, Tochigi, Japan.
- Department of Translational Research, Clinical Research Center, Jichi Medical University Hospital, 3311-1, Yakushiji, Shimotsuke 329-0498, Tochigi, Japan.
- Jichi Medical University, 3311-1, Yakushiji, Shimotsuke 329-0498, Tochigi, Japan.
- Clinical Pharmacology Center, Jichi Medical University Hospital, 3311-1, Yakushiji, Shimotsuke 329-0498, Tochigi, Japan.
ORCID-Profile: Hideo Ogiso
Förderung
- JSPS KAKENHI
- Kawano Masanori Memorial Foundation for the Promotion of Pediatrics
Zitieren
APA
Kanai, T., Ogiso, H., Aoyagi, J., Kurosaki, M., Maru, T., Ishii, M., Tanimoto, K., Yoshino, M., Yamashita, Y., Tajima, T., Nagai, R., & Aizawa, K. (2025). Altered Sphingolipids, Glycerophospholipids, and Lysophospholipids Reflect Disease Status in Idiopathic Steroid-Sensitive Nephrotic Syndrome in Children: A Non-Targeted Metabolomic Study. Cells. https://doi.org/10.3390/cells14241950
Vancouver
Kanai T, Ogiso H, Aoyagi J, Kurosaki M, Maru T, Ishii M, et al. Altered Sphingolipids, Glycerophospholipids, and Lysophospholipids Reflect Disease Status in Idiopathic Steroid-Sensitive Nephrotic Syndrome in Children: A Non-Targeted Metabolomic Study. Cells. 2025. doi:10.3390/cells14241950
BibTeX
@article{Kanai2025,
author = {Kanai, Takahiro and Ogiso, Hideo and Aoyagi, Jun and Kurosaki, Masanori and Maru, Tomomi and Ishii, Marika and Tanimoto, Kazuya and Yoshino, Mitsuaki and Yamashita, Yuri and Tajima, Toshihiro and Nagai, Ryozo and Aizawa, Kenichi},
title = {Altered Sphingolipids, Glycerophospholipids, and Lysophospholipids Reflect Disease Status in Idiopathic Steroid-Sensitive Nephrotic Syndrome in Children: A Non-Targeted Metabolomic Study},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14241950}
}
EUVIMED